close
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
The European Commission has authorized GSK’s HIV-focused unit ViiV Healthcare’s cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.
EUROPEAN COMMISSION CHIEF URSULA VON DER LEYEN ASSURES AID TO FLOOD-STRICKEN SLOVENIA DURING VISIT
Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acquired HIV-1 infection in high-risk adults and adolescents weighing at least 77.16 pounds, according to the company.
The GlaxoSmithKline logo is seen in this illustration, Aug. 10, 2022. (REUTERS/Dado Ruvic/Illustration/File Photo)
Sold under brand name Apretude, it is currently approved for use in the United States, Australia, Zimbabwe, South Africa, Malawi, Botswana and Brazil.
CLICK HERE TO GET THE FOX NEWS APP
close Video Fox News Flash top headlines for November 16 Fox News Flash top headlines…
President Biden awkwardly stood in the back corner of the Asia-Pacific Economic Cooperation (APEC) family…
President-elect Trump announced that William Owen Scharf, one of his lawyers, will serve as assistant…
With Republicans sweeping to a red trifecta in last week’s elections, stunningly capturing the White House…
With President-elect Trump headed back to the White House and Republicans in the majority in…
Republicans in a majority-Latino district in California that includes Indio and Coachella are on course…